All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Asia EquityAsia ABBs and Block Trades

Temasek trims Celltrion stake in $1bn block duo

Allergen_Pills_Pharma_23May2017_Fotolia_230x150

Temasek Holdings made a splash in the block market this week, raising W1.07tr ($1bn) with a pair of overnight trades in South Korean pharmaceutical company Celltrion and its distribution arm Celltrion Healthcare — an approach that was in line with the Singapore sovereign wealth fund’s strategy to rebalance its portfolio. Jonathan Breen reports.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree